Objective
The market for testing of pharmaceuticals and the demand for human cells for cell therapies will grow substantially. Conventional cell culture and organ- model systems (C-CCW) are complex and expensive, due to chemical coating compounds requiring multiple production steps, and marginally effective as cells stay alive for short periods and/or grow at low speed. The performance of cell culture systems and organ model systems can be dramatically improved by using materials with designed surface topography.
Materiomics has invented an innovative TopoChip high-throughput screening technology. The overall aim is to innovatively set up enabling technology to transfer the designed topographies to C-CCW products in a high-volume, low-cost manufacturing process (leading to phase 2 application). It creates the next generation products: Functionalized Cell Culture Ware ( F-CCW )which is simple, highly effective and efficient.
Goals in Phase 1 are to:
1. Demonstrate the technical feasibility of transferring designed topographies on C-CCW
2. Explore commercial feasibility of F-CCW: to develop a business plan.
3. Develop production methods for producing F-CCW
4. Select cell culture system applications that allow for the highest expected economic return on investment.
5. Identify (and contact) network partnerships for creating a production facility for F-CCW’s
Potential end users are research driven industries of drug development, toxicology, personalized medicine and cell therapeutics. Potential stakeholders are investors, injection moulding specialists, manufacturers of moulds for inlay, testing and research laboratories for medical and toxicological testing and pharmaceutical industry. The market is a global market (EU, US and upcoming Asian markets).
F-CCW is a breakthrough in functionality of cell culture. Since F-CCW is not limited to one application only, F-CCW will offer multiple follow-up investment opportunities and create many opportunities for new venture
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- engineering and technologymechanical engineeringmanufacturing engineering
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- natural sciencesphysical sciencesastronomyplanetary sciencesplanetary geology
- engineering and technologymaterials engineeringcoating and films
- medical and health sciencesmedical biotechnologycells technologies
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback.
You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Call for proposal
(opens in new window) H2020-SMEInst-2014-2015
See other projects for this callSub call
H2020-SMEINST-1-2015
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
6229 EV MAASTRICHT
Netherlands
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.